(現在 過去ログ28307 を表示中)

HOME HELP 新規作成 新着記事 トピック表示 ファイル一覧 検索 過去ログ

[ 最新記事及び返信フォームをトピックトップへ ]

■1685159 / inTopicNo.1)  tkHicAqpnAyodwI
  
□投稿者/ Freddy -(2019/12/15(Sun) 17:43:23) [ID:0qxMLcR0]
http://www.netmarks.co.th/index.php/cleocin-suppositories-fd64.pdf
    Where do you come from? https://www.atalaytasarim.com/childrens-motrin-tablets-dosage-cce6.pdf when to give baby motrin for fever  Maintenance of an 'A-' IDR for MCK will require debt-to-EBITDA of 1.4x or below. The ratings could be maintained if acquisition funding results in temporary increases above this range, depending on the company's ability and willingness to de-lever (e.g. the recent PSS World Medical, Inc. acquisition). Based on a preliminary analysis of the potential acquisition of Celesio by MCK, Fitch expects debt-to-EBITDA will be sustained above 1.4x for an extended period. Consequently, a downgrade of MCK's long-term ratings is likely, pending the successful consummation of the deal.
     

引用返信/返信 削除キー/



トピック内ページ移動 / << 0 >>

このトピックに書きこむ

書き込み不可

Mode/  Pass/

HOME HELP 新規作成 新着記事 トピック表示 ファイル一覧 検索 過去ログ

- Child Tree -